Aurobindo gets FDA nod for anti-depression generic

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxala...Read more

Canada quarantines APIs by India firm

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2015

Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sr...Read more

Fosun Pharma listed in CCTV Financial 50 Index Sample Stock

Generics |  Company results | By BioSpectrum Bureau  | 8 Comment | 14 Aug, 2013

Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...Read more

First generic of diabetes drug Actos approved

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

Singapore: The US FDA has approved world's first generic version of Actos (pioglitazone hydrochloride) tablets. US-based...Read more

Ranbaxy redesigns strategy to meet regulations

Generics |  Analysis | By BioSpectrum Bureau  | 3 Comment | 12 Jun, 2012

The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...Read more

Interpol seized $41 mn fake drugs to be sold online

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

Singapore: Interpol's sixth and the biggest annual worldwide crackdown, Pangea VI has ended in seizing of $41 million wo...Read more

India, China to produce generic of Gilead's TAF

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2014

Singapore: Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV d...Read more

Indian formulation industry to grow by 10-12%

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: The Indian pharmaceutical industry is estimated to continue to experience strong growth in the near-term alth...Read more

Dr. Reddy's hires its HR global head from IBM

Generics |  Influencers | By BioSpectrum Bureau  | 2 Comment | 13 Aug, 2013

Singapore: India's pharmaceutical firm Dr. Reddy's has appointed Dr. Sripada Chandrasekhar as the president and global h...Read more

Huahai gets China FDA nod to make HIV/AIDS generic

Generics |  Regulatory | By BioSpectrum Bureau  | 2 Comment | 25 Sep, 2013

Singapore: China-based Zhejiang Huahai Pharma received approval from the China FDA to produce efavirenz. Huahai is the f...Read more

US firms lobbying to protect patents in India: Report

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

Singapore: An Indian news report that appeared in Business Line quoted an unidentified DIPP official who claimed that to...Read more

Merck aims to expand its China business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2014

Singapore: Leading pharma giant Merck has reinforced its commitments towards China, in a bid to strengthen its position ...Read more

Blogger sued by pharma firm for the first time in India

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juri...Read more

Actavis sets up APAC headquarter in Singapore

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2014

Singapore: Global generics firm, Actavis, has opened its regional office in Singapore that will serve as the headquarter...Read more

Indian regulator cracks down on banned drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2013

Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the count...Read more

Why Mylan sued US FDA over Diovan generic?

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic...Read more

Ranbaxy now recalls 64,000 bottles of generic heart drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehension...Read more

APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 28 Feb, 2014

Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...Read more